Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the cell wall
- 21 February 2006
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 60 (1) , 93-107
- https://doi.org/10.1111/j.1365-2958.2006.05082.x
Abstract
The role of capsular polysaccharides and several virulence-related proteins in the pathogenic potential of Streptococcus pneumoniae has been studied extensively. Much less information is available about the role of the pneumococcal cell wall in virulence. In this communication we describe an experimental system that has allowed us to test - in a global way - the role of choline, a structural component of the pneumococcal cell wall, in virulence. We constructed double mutants of S. pneumoniae which have lost the auxotrophic requirement for choline and which were also blocked from utilizing choline from the growth medium. Such a double mutant expressing type 2 capsule but completely lacking choline residues from its cell wall grew well both in vitro and also in the blood of infected mice, but showed striking reduction of virulence approaching that of a capsule-free strain in several models of pneumococcal disease including the capacity to attach and invade a human nasopharyngeal cell line; nasal colonization and intraperitoneal and intravenous inoculation in the mouse. The findings allow one to separate the choline requirement of S. pneumoniae into two sharply defined classes: the need for choline in growth and replication which can be effectively bypassed and the need for choline in pneumococcal virulence that appears to be irreplaceable. The double mutant should be a useful experimental tool to dissect the mechanism of choline requirement in various stages of pneumococcal virulence.Keywords
This publication has 43 references indexed in Scilit:
- Insights into pneumococcal pathogenesis from the crystal structure of the modular teichoic acid phosphorylcholine esterase PceNature Structural & Molecular Biology, 2005
- Structure and Mechanism of CTP:Phosphocholine Cytidylyltransferase (LicC) from Streptococcus pneumoniaeJournal of Biological Chemistry, 2002
- The CTP:phosphocholine cytidylyltransferase encoded by the licC gene of Streptococcus pneumoniae: cloning, expression, purification, and characterizationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2001
- An rpsL Cassette, Janus, for Gene Replacement through Negative Selection in Streptococcus pneumoniaeApplied and Environmental Microbiology, 2001
- The licC Gene of Streptococcus pneumoniae Encodes a CTP:Phosphocholine CytidylyltransferaseJournal of Bacteriology, 2001
- Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniaeInfection and Immunity, 2000
- Pneumococcal licD2 gene is involved in phosphorylcholine metabolismMolecular Microbiology, 1999
- Autolysis and Cell Wall Degradation in a Choline-Independent Strain ofStreptococcus pneumoniaeMicrobial Drug Resistance, 1997
- Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).The Journal of Experimental Medicine, 1987
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985